TRML
Tourmaline Bio Inc.
$47.90
+$0.03(+0.05%)
62
Overall
60
Value
91
Tech
36
Quality
Market Cap
$1.23B
Volume
197.77K
52W Range
$11.56 - $48.27
Target Price
$48.55
Key Metrics Overview
| Market Cap | $1.23B | P/E Ratio | N/A |
| 52W High | $48.27 | 52W Low | $11.56 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 99.0% |
| Overall Score | 62 | Value Score | 60 |
| Quality Score | 36 | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $-3.75 | EPS Next Est | $-4.19 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRML | $47.90 | +0.1% | 197.77K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |